Research any topic before you write.

Find related topics. | Discover entities. | See connections. | Build a topical map.

Nirsevimab

Nirsevimab, sold under the brand name Beyfortus, is a human recombinant monoclonal antibody with activity against respiratory syncytial virus (RSV). It is a respiratory syncytial virus (RSV) F protein‑directed fusion inhibitor that is designed to bind to the fusion protein on the surface of the RSV virus.

History, Applications & Research

Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.

Research this topic

Explore the main themes, entities and connections around Nirsevimab. Start with the topic map, then use the sections below for research and deeper semantic analysis.

Explore this topic

Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

AHFS/Drugs.com
Micromedex Detailed Consumer Information
ATC code
J06BD08 (WHO)
CAS Number
1989556-22-0
ChEMBL
ChEMBL4297575
DrugBank
DB16258
Formula
C6494H10060N1708O2050S46

Topics to explore

Browse the full topic structure. Each item opens a new analysis centered on that subject.

Overview

Medical uses

Pharmacology

History

Research

Advanced semantic analysis

Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.

Map overview Semantic statistics

Nirsevimab

Nodes29
Edges28
Triples69
Avg. degree1.93
Density0.068966
Components1

How this topic connects Entity context

See the strongest relationship patterns around the current topic before diving into the raw triples.

Nirsevimab

Top relations

related to Legal status · 18
Nirsevimab → April, AstraZeneca AB, Beyfortus, Canada, Committee, EMA's, European Medicines Agency, European Union, Human Use, In November, In September, It, July, Medicinal Products, RSV, The, United Kingdom, United States
related to history · 8
Nirsevimab → Committee, European Medicines Agency, Human Use, II/III, Medicinal Products, RSV, Synagis, The
related to Medical uses · 8
Nirsevimab → Alternatively, CDC, European Union, In, October, RSV, RSVpreF, United States
related to Research · 6
Nirsevimab → April, As, Initial, LRTI, RSV, The MELODY
Legal status · 5
Nirsevimab → AU: S4 (Prescription only), CA: ℞-only / Schedule D, EU: Rx-only, UK: POM (Prescription only), US: ℞-only
related to Mechanism of action · 3
Nirsevimab → Fc, It, RSV
Other names · 2
Nirsevimab → MEDI8897, nirsevimab-alip
has effect · 2
Nirsevimab → NCT02878330, No
AHFS/Drugs.com · 1
Nirsevimab → Micromedex Detailed Consumer Information
ATC code · 1
Nirsevimab → J06BD08 (WHO)

Important terminology Word statistics

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

rsv infants respiratory preterm 2023 trial safety disease placebo lrti april virus lower tract season randomized ma use syncytial beyfortus

Entity relationships Subject–Predicate–Object triples

SubjectPredicateObjectConfidenceSrc
NirsevimabAHFS/Drugs.comMicromedex Detailed Consumer Information1.00infobox
NirsevimabATC codeJ06BD08 (WHO)1.00infobox
NirsevimabCAS Number1989556-22-01.00infobox
NirsevimabChEMBLChEMBL42975751.00infobox
NirsevimabDrugBankDB162581.00infobox
NirsevimabFormulaC6494H10060N1708O2050S461.00infobox
NirsevimabKEGGD113801.00infobox
NirsevimabLegal statusAU: S4 (Prescription only)1.00infobox
NirsevimabLegal statusCA: ℞-only / Schedule D1.00infobox
NirsevimabLegal statusUK: POM (Prescription only)1.00infobox
NirsevimabLegal statusUS: ℞-only1.00infobox
NirsevimabLegal statusEU: Rx-only1.00infobox
NirsevimabLicense dataUS DailyMed: Nirsevimab1.00infobox
NirsevimabMolar mass146336.58 g·mol−11.00infobox
NirsevimabOther namesMEDI88971.00infobox
NirsevimabOther namesnirsevimab-alip1.00infobox
NirsevimabPregnancy categoryAU: B21.00infobox
NirsevimabPubChem SID3845853581.00infobox
NirsevimabRoutes of administrationIntramuscular1.00infobox
NirsevimabSourceHuman1.00infobox
NirsevimabTargetF protein of RSV1.00infobox
NirsevimabTrade namesBeyfortus1.00infobox
NirsevimabTypeWhole antibody1.00infobox
NirsevimabUNIIVRN8S9CW5V1.00infobox

Related concept clusters Concept neighborhoods

These clusters group vocabulary that occurs around closely connected concepts in the source material.

    Connections between topic areas Semantic bridges

    Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.

    Min side: 3
    For writers, content strategists, SEOs, marketers and creators — from quick topic research to advanced semantic analysis.